Summary:
[unable to retrieve full-text content]In recent weeks, as the United States has ramped up its attacks on Chinese tech firms and the threat of financial decoupling has grown, government advisers in Beijing have begun debating a so-called nuclear option: cutting US access to medicines.From pills for pain relief to HIV medications, the US is heavily reliant on imported medicines from China thanks to large-scale offshoring in the 1990s.While weaponising drug exports and precursors does not have official backing, its discussion has…
Topics:
Cissy Zhou considers the following as important:
This could be interesting, too:
[unable to retrieve full-text content][unable to retrieve full-text content]In recent weeks, as the United States has ramped up its attacks on Chinese tech firms and the threat of financial decoupling has grown, government advisers in Beijing have begun debating a so-called nuclear option: cutting US access to medicines.From pills for pain relief to HIV medications, the US is heavily reliant on imported medicines from China thanks to large-scale offshoring in the 1990s.While weaponising drug exports and precursors does not have official backing, its discussion has…
Topics:
Cissy Zhou considers the following as important:
This could be interesting, too:
Doug Short writes S&P 500 Snapshot: World of 4K
Calculated Risk writes Lawler: Early Read on Existing Home Sales in March
Mike Shedlock writes Housing is Going Gangbusters, Thank Covid-19 and the Fed
Doug Short writes Long-Term Look at the CPI
In recent weeks, as the United States has ramped up its attacks on Chinese tech firms and the threat of financial decoupling has grown, government advisers in Beijing have begun debating a so-called nuclear option: cutting US access to medicines.From pills for pain relief to HIV medications, the US is heavily reliant on imported medicines from China thanks to large-scale offshoring in the 1990s.While weaponising drug exports and precursors does not have official backing, its discussion has…